Polymedica Corp (MM)【PLMD】株式ニュース

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

Polymedica Corp-Notification of removal from listing & reg. of matured, redeemed/retired sec. Initial Filing Amendments (25-NSE)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION...

Polymedica Corp - Current report filing (8-K)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

Standard & Poor's Announces Changes to U.S. Index

NEW YORK, Oct. 25 /PRNewswire/ -- Standard & Poor's will make the following changes to the S&P SmallCap 600 index after the close of trading on...

Polymedica Corp - Amended Statement of Beneficial Ownership (SC 13D/A)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934...

Polymedica Corp - Amended Statement of Beneficial Ownership (SC 13D/A)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934...

Polymedica Corp - Current report filing (8-K)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

Polymedica Corp - Additional Proxy Soliciting Materials (definitive) (DEFA14A)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

Polymedica Corp - Amended Statement of Beneficial Ownership (SC 13D/A)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934...

Polymedica Corp (Other) (DEFM14A)

Table of Contents United States Securities and Exchange Commission Washington, DC 20549 SCHEDULE 14A...

Polymedica Corp (Other) (SC 13D)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 PolyMedica Corporation (Name of...

Polymedica Corp (Other)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...

Polymedica Corp - Additional Proxy Soliciting Materials (definitive) (DEFA14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...

Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion

-- Strategic Acquisition Creates Premier Provider of Diabetes Care Services With 3.8 Million Patients Under Treatment FRANKLIN LAKES, N.J. and...

Polymedica to Participate in Noble Financial Small Cap Conference/Micro Cap Symposium

PolyMedica Corporation (NASDAQ: PLMD) announced today that it will participate in the Noble Financial Small Cap Conference/Micro...

投稿がありません

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター